Abbott India Ltd (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review
Description
Abbott India Ltd (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Abbott India Ltd (Abbott India), a subsidiary of Abbott Laboratories, develops, manufactures, and distributes science-based nutritional products, diagnostic tools, branded generic pharmaceuticals, and diabetes and vascular devices. The company's major activities revolve around translating science into lasting contributions to health, with a focus on diverse therapeutic areas such as women's health, gastroenterology, cardiology, metabolic disorders, and primary care. Its product portfolio encompasses multi-speciality drugs, vitamins, and products for the treatment of epilepsy, hypothyroidism, vertigo, migraine, and depression. The company’s offerings also include vaccines for influenza, typhoid, and diarrhoea. Abbott India develops pharmaceuticals in various formulations, including tablets, injectables, liquids, ointments, granules, powder, and capsules. The product range helps treat gynaecological, gastroenterological, urological, and neurological diseases, diabetes, pain, and infection. The company has a manufacturing facility in Goa, India. Abbott India is headquartered in Mumbai, Maharashtra, India.
Abbott India Ltd Key Recent Developments
Nov 13,2025: Abbott Introduces Advanced Ensure Diabetes Care Formula for Blood Sugar Management
Sep 24,2025: Abbott India Announces Resignation of Senior Management Personnel of the Company
Feb 20,2025: Abbott : Resignation of Senior Management Personnel of the Company
Feb 20,2025: Abbott India: Resignation of Senior Management Personnel of the Company
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Abbott India Ltd (Abbott India), a subsidiary of Abbott Laboratories, develops, manufactures, and distributes science-based nutritional products, diagnostic tools, branded generic pharmaceuticals, and diabetes and vascular devices. The company's major activities revolve around translating science into lasting contributions to health, with a focus on diverse therapeutic areas such as women's health, gastroenterology, cardiology, metabolic disorders, and primary care. Its product portfolio encompasses multi-speciality drugs, vitamins, and products for the treatment of epilepsy, hypothyroidism, vertigo, migraine, and depression. The company’s offerings also include vaccines for influenza, typhoid, and diarrhoea. Abbott India develops pharmaceuticals in various formulations, including tablets, injectables, liquids, ointments, granules, powder, and capsules. The product range helps treat gynaecological, gastroenterological, urological, and neurological diseases, diabetes, pain, and infection. The company has a manufacturing facility in Goa, India. Abbott India is headquartered in Mumbai, Maharashtra, India.
Abbott India Ltd Key Recent Developments
Nov 13,2025: Abbott Introduces Advanced Ensure Diabetes Care Formula for Blood Sugar Management
Sep 24,2025: Abbott India Announces Resignation of Senior Management Personnel of the Company
Feb 20,2025: Abbott : Resignation of Senior Management Personnel of the Company
Feb 20,2025: Abbott India: Resignation of Senior Management Personnel of the Company
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
53 Pages
- Section 1 - About the Company
- Abbott India Ltd - Key Facts
- Abbott India Ltd - Key Employees
- Abbott India Ltd - Key Employee Biographies
- Abbott India Ltd - Major Products and Services
- Abbott India Ltd - History
- Abbott India Ltd - Company Statement
- Abbott India Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Abbott India Ltd - Business Description
- R&D Overview
- Abbott India Ltd - Corporate Strategy
- Abbott India Ltd - SWOT Analysis
- SWOT Analysis - Overview
- Abbott India Ltd - Strengths
- Abbott India Ltd - Weaknesses
- Abbott India Ltd - Opportunities
- Abbott India Ltd - Threats
- Abbott India Ltd - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Abbott India Ltd, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Nov 13, 2025: Abbott Introduces Advanced Ensure Diabetes Care Formula for Blood Sugar Management
- Sep 24, 2025: Abbott India Announces Resignation of Senior Management Personnel of the Company
- Feb 20, 2025: Abbott India: Resignation of Senior Management Personnel of the Company
- Feb 20, 2025: Abbott : Resignation of Senior Management Personnel of the Company
- Feb 03, 2025: Abbott India: GI Businesses has Been Promoted to Another Affiliate of Abbott in India
- Feb 03, 2025: Abbott India : Mr. Kunal Chowdhury as a Commercial Director
- Jan 21, 2025: Abbott India Makes Senior Management Change
- Jan 16, 2025: Abbott India : Designation of Senior Management Personnel of the Company
- Jan 03, 2025: Abbott India : Intimation Under Regulation 30 of Securities and Exchange Board of India Regulations, 2015 - Change in Senior Management of Company
- Dec 16, 2024: Abbott Announces Resignation of Whole Time Director
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Abbott India Ltd, Key Facts
- Abbott India Ltd, Key Employees
- Abbott India Ltd, Key Employee Biographies
- Abbott India Ltd, Major Products and Services
- Abbott India Ltd, History
- Abbott India Ltd, Other Locations
- Abbott India Ltd, Key Competitors
- Abbott India Ltd, Ratios based on current share price
- Abbott India Ltd, Annual Ratios
- Abbott India Ltd, Annual Ratios (Cont...1)
- Abbott India Ltd, Annual Ratios (Cont...2)
- Abbott India Ltd, Interim Ratios
- Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Abbott India Ltd, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Abbott India Ltd, Performance Chart (2021 - 2025)
- Abbott India Ltd, Ratio Charts
- Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Abbott India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
